What is Biological E?
Biological E. Limited operates as a premier biopharmaceutical entity, specializing in the development, manufacturing, and distribution of vaccines and injectable pharmaceuticals. The company is distinguished by its commitment to high-quality, affordable healthcare solutions, serving as a vital partner in global public health initiatives. Through its advanced manufacturing capabilities and rigorous adherence to international regulatory standards, Biological E. addresses the urgent demand for infectious disease management. Its market position is defined by a dual focus on domestic supply chain resilience and international collaboration, positioning it as a key player in the global effort to mitigate health crises through innovation and scalable production models.
How much funding has Biological E raised?
Biological E has raised a total of $5M across 1 funding round:
Grant
$5M
Grant (2020): $5M with participation from Coalition for Epidemic Preparedness Innovations
Key Investors in Biological E
Coalition for Epidemic Preparedness Innovations
A global partnership of public, private, philanthropic, and civil society organizations that finances and coordinates the development of vaccines against high-priority epidemic threats.
What's next for Biological E?
With this major enterprise-level funding, Biological E. is poised to accelerate its research and development pipeline while expanding its manufacturing footprint. The strategic allocation of this capital will likely focus on enhancing production capacity for next-generation vaccines and diversifying its portfolio of specialty biologic products. As the company navigates the complexities of the post-pandemic healthcare environment, its focus will remain on strengthening global partnerships and optimizing supply chain logistics. This growth trajectory suggests a transition toward broader market penetration and the potential for new therapeutic breakthroughs that align with the company's mission of improving global health outcomes through sustainable and scalable biopharmaceutical solutions.
See full Biological E company page
